Table 4 Number of drugs taken by male and female MS patients in different age groups
From: Polypharmacy in patients with multiple sclerosis: a gender-specific analysis
Age (years) | ≤ 29 | 30–39 | 40–49 | 50–59 | ≥ 60 | |
|---|---|---|---|---|---|---|
N | 23 | 64 | 64 | 96 | 59 | |
Number of PwP (%) | Female | 4 (20.0) | 16 (34.8) | 23 (54.8) | 40 (60.6) | 39 (88.6) |
Male | 1 (33.3) | 8 (44.4) | 10 (45.5) | 20 (66.7) | 12 (80.0) | |
p valueFi | 0.539 | 0.569 | 0.600 | 0.653 | 0.407 | |
Number of drugsa | Female | 3.1 (1.4) | 4.1 (2.1) | 5.1 (3.1) | 6.3 (3.7) | 9.0 (4.1) |
Male | 4.0 (2.0) | 4.6 (2.7) | 4.7 (3.3) | 5.3 (2.8) | 7.3 (3.5) | |
p valuet | 0.316 | 0.501 | 0.638 | 0.178 | 0.152 | |
Mean difference in the number of drugs* | − 0.9 | − 0.5 | 0.4 | 1.0 | 1.7 | |